Skip to main content

Gabriela Guillén Burrieza

I am a pediatric surgeon, and since completing my specialist training I have subspecialized in the surgical treatment of pediatric and adolescent cancer. I am currently section head of the Oncological, Neonatal and Hepatobiliopancreatic Surgery unit of the Pediatric Surgery Department. My goal is to provide comprehensive care to our patients, which meets the highest quality standards, the incorporation of cutting edge technologies and the maximum scientific evidence, from a humanistic approach that puts the patient and their family at the center of care.

Institutions of which they are part

Predoctoral researcher
Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca
Head of Section
Paediatric Oncological Surgery
Children's Hospital and Woman's Hospital

Gabriela Guillén Burrieza

Institutions of which they are part

Predoctoral researcher
Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca
Head of Section
Paediatric Oncological Surgery
Children's Hospital and Woman's Hospital

I am a pediatric surgeon, and since completing my specialist training I have subspecialized in the surgical treatment of pediatric and adolescent cancer. I am currently section head of the Oncological, Neonatal and Hepatobiliopancreatic Surgery unit of the Pediatric Surgery Department. My goal is to provide comprehensive care to our patients, which meets the highest quality standards, the incorporation of cutting edge technologies and the maximum scientific evidence, from a humanistic approach that puts the patient and their family at the center of care.

Graduated in Medicine from the University of Salamanca, I did my specialty training in Pediatric Surgery at Vall d'Hebron Hospital. Since 2008 I have been part of the Pediatric Surgery department, first as an staff member and currently as head of section.
Between 2008 and 2017 I was also tutor for doctors in training.

My main area of ​​specialization is pediatric surgical oncology, where I have focused most of my clinical practice and research projects, although other areas of my interest are neonatal, hepatobiliary and thoracic surgery.

I have been a member of the European Pediatric Soft Tissue Sarcoma Study Group since 2012, first as part of the surgical subcommittee and since 2020, as part of the Board. In addition, I belong to and collaborate with other European pediatric cancer expert groups (SIOPEN, RTSG, EXPERT, SIOPEL), international (IPSO) and I am consultant for several national groups (SEHOP groups in soft tissue sarcomas, rare tumors and renal tumors ). Since 2024, I have been president of GRECOP (Spanish Group of Pediatric Surgical Oncology).

In 2023, I presented my PhD at the Universitat Autònoma de Barcelona, ​​titled "Development of Orthotopic PDX (Patient-Derived Xenografts) for Pediatric Extracranial Solid Tumors", focused on the generation of preclinical models in childhood cancer, achieving an excellent Cum Laude qualification.

To date, I have published more than 70 scientific papers and book chapters, as an author or co-author, and I participate in several research projects both in pediatric cancer and in other areas of my specialty. I currently combine several research projects in pediatric cancer, as a member of the research group in Cancer and Children's Hematological Diseases of the VHIR, with more purely surgical projects (applications of intraoperative fluorescence, 3D reconstructions, development of minimally invasive techniques, projects of humanization in surgery, among others).

Projects

Bioenginyeria, Ortopèdia i Cirurgia Pediàtriques (GRC)

IP: César Galo García Fontecha
Collaborators: Margarita Codinach Creus, Vicenç Martínez Ibáñez, José Luis Peiró Ibáñez, Carlos Giné Prades, Juan A. Porcel Vázquez, Francisco Soldado Carrera, Luciano Rodríguez Gómez, Mario Marotta Baleriola, Laura Fresno Bermejo, Gabriela Guillén Burrieza
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding:
Reference: 2014 SGR 1401
Duration: 01/01/2014 - 31/12/2016

Reparación fetoscópica uniportal del mielomeningocele utilizando células progenitoras amnióticas en oveja

IP: César Galo García Fontecha
Collaborators: Margarita Codinach Creus, Marta Garrido Pontnou, Luciano Rodríguez Gómez, Maite Avilés García, Gabriela Guillén Burrieza
Funding agency: Instituto de Salud Carlos III
Funding: 75020
Reference: PI10/02466
Duration: 01/01/2011 - 30/06/2014

Bioenginyeria, ortopèdia i cirurgia pediàtriques

IP: César Galo García Fontecha
Collaborators: Roberto Vélez Villa, Margarita Codinach Creus, Vicenç Martínez Ibáñez, José Luis Peiró Ibáñez, Carlos Giné Prades, Francisco Soldado Carrera, Màrius Aguirre Canyadell, Luciano Rodríguez Gómez, Carles Amat Mateu, Mario Marotta Baleriola, Gabriela Guillén Burrieza
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding:
Reference: 2009 SGR 130
Duration: 01/01/2010 - 30/04/2014

Related news

The meeting was an opportunity to get to know projects from both institutions and to promote interaction between professionals.

A study jointly led by the Hospital Clínic of Barcelona and the Vall d'Hebron Research Institute (VHIR) confirms the effectiveness of neonatal screening in reducing morbidity among children with sickle cell disease (SCD).

Active participation by patients and families in studies helps identify more effective therapies that improve quality of life and survival.

Related professionals

Edoardo Caronna

Edoardo Caronna

Postdoctoral researcher
Headache and Neurological Pain
Read more
Selen Ozkan

Selen Ozkan

Predoctoral researcher
Clinical and Translational Bioinformatics
Read more
Maria Victoria Gonzalez Martinez

Maria Victoria Gonzalez Martinez

Senior researcher
Pediatric Neurology
Read more
Tamara Garcia Antolinez

Tamara Garcia Antolinez

Zelador/a
General Services and Infrastructures Unit
Manager
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.